Daniel Rudoy Image

Daniel Rudoy

Shareholder, Electrical & Computer Technologies Practice

Wolf Greenfield

Dan Rudoy, Ph.D. is a shareholder at Wolf Greenfield. Dan focuses his practice on IP counseling, patent portfolio development, and patent prosecution for clients developing technology in a wide variety of areas including artificial intelligence, bioinformatics, electronics, genomics, machine learning, medical devices, and software. Dan has particular experience working with clients developing technology at the intersection of life sciences and electrical and computer technology, for example, the application of machine learning to the analysis of genomic data.Dan works regularly with start-ups, mid-size and multinational companies, non-profit organizations, and investors, advising them on all aspects of IP strategy and portfolio development both in the United States and abroad. Dan works with clients on many IP issues beyond patent prosecution including due diligence, trade secrets, licensing, freedom to operate, and litigation.Dan is a member of Wolf Greenfield’s Executive Committee. In addition, he plays an active role in the training and development of technology specialists, patent agents, and attorneys. He leads the training program in the Electrical & Computer Technologies Practice and oversees firm-wide junior trainings. Dan is also involved in creating and overseeing the firm-wide leadership development program for senior attorneys.

Recent Articles by Daniel Rudoy

Protection Strategies for Growth-Phase Companies

When it comes to the IP rights of your competitors, what you don’t know can hurt you. As your company brings new products to the marketplace, you should consider taking steps to ensure that doing so does not infringe on the patent rights of your competitors or other companies. Understanding what is in the patent portfolios of your competitors and the IP landscape in general is key to avoiding surprises and reducing risk when commercializing products. Competitor landscape reviews may also provide valuable insight into your own patenting strategy. To this end, many companies perform so-called “freedom to operate” (FTO) studies with the goal of identifying any potential IP barriers to market entry and the associated risks of future litigation.

Past Events with Daniel Rudoy